InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ling Karen, Director. Officer active across 2 companies, notably TherapeuticsMD, Inc.. Cumulatively, 7 disclosures have been published. Total volume traded: €43k. The latest transaction was filed on 26 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
0653 shares0
Common Stock
SEC:0001388658-22-000072:0·
04,320 shares0
Common Stock
SEC:0001388658-21-000147·
04,320 shares0
Common Stock
SEC:0001388658-21-000147:0·
€21,42133,445 shares@ €0.64050.093% mcap100.0% of flow
Common Stock
SEC:0001387131-21-008750·
Ideal exit: 14 May 2022 (T+270)
€21,42133,445 shares@ €0.64050.093% mcap50.0% of flow
Common Stock
SEC:0001387131-21-008750:0·
Ideal exit: 14 May 2022 (T+270)
96,864 shares
Common Stock
SEC:0001387131-21-008433·
96,864 shares
Common Stock
SEC:0001387131-21-008433:0·
7 of 7 declarations
About Ling Karen
Ling Karen serves as a Director at TherapeuticsMD, Inc. and iRhythm Technologies, Inc. She participates in the governance of these companies and strategic decision-making. Her expertise is valuable in guiding direction and ensuring performance.
